REGN Return on Tangible Equity | REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC. (REGN) Return on Tangible Equity

2026-06-30: Return Tang Equity 14.06%.
2026-03-31: Return Tang Equity 14.50%.
2025-12-31: Return Tang Equity 14.85%.
2025-09-30: Return Tang Equity 15.24%.

Complete source-backed return tang equity history.

Available history: 2008-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	14.06%
2026-03-31	14.50%
2025-12-31	14.85%
2025-09-30	15.24%
2025-06-30	15.36%
2025-03-31	15.80%
2024-12-31	15.52%
2024-09-30	16.38%
2024-06-30	15.84%
2024-03-31	14.79%
2023-12-31	15.78%
2023-09-30	16.64%
2023-06-30	18.61%
2023-03-31	18.52%
2022-12-31	19.95%
2022-09-30	26.17%
2022-06-30	27.50%
2022-03-31	39.85%
2021-12-31	43.04%
2021-09-30	40.53%
2021-06-30	41.02%
2021-03-31	33.43%
2020-12-31	31.86%
2020-09-30	31.17%
2020-06-30	32.94%
2020-03-31	18.79%
2019-12-31	19.08%
2019-09-30	20.41%
2019-06-30	21.21%
2019-03-31	25.70%
2018-12-31	27.91%
2018-09-30	22.85%
2018-06-30	22.14%
2018-03-31	21.74%
2017-12-31	19.51%
2017-09-30	21.12%
2017-06-30	20.91%
2017-03-31	19.79%
2016-12-31	20.13%
2016-09-30	17.75%
2016-06-30	18.23%
2016-03-31	19.69%
2015-12-31	17.40%
2015-09-30	17.32%
2015-06-30	13.30%
2015-03-31	11.64%
2014-12-31	13.26%
2014-09-30	13.10%
2014-06-30	16.55%
2014-03-31	17.33%
2013-12-31	21.06%
2013-09-30	47.21%
2013-06-30	56.79%
2013-03-31	59.55%
2012-12-31	59.71%
2012-09-30	28.09%
2012-06-30	-4.61%
2012-03-31	541.36%
2011-12-31	-45.65%
2011-09-30	-42.71%
2011-06-30	-32.30%
2011-03-31	-22.66%
2010-12-31	-19.79%
2010-09-30	-36.30%
2010-06-30	-25.19%
2010-03-31	-21.48%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	14.85%
2024-12-31	15.52%
2023-12-31	15.78%
2022-12-31	19.95%
2021-12-31	43.04%
2020-12-31	31.86%
2019-12-31	19.08%
2018-12-31	27.91%
2017-12-31	19.51%
2016-12-31	20.13%
2015-12-31	17.40%
2014-12-31	13.26%
2013-12-31	21.06%
2012-12-31	59.71%
2011-12-31	-45.65%
2010-12-31	-19.79%
2009-12-31	-17.10%
2008-12-31	-18.77%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64
Viatris Inc (VTRS)	United States	$20.008B	-0.00
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07